Fighting cancer is something that nobody can do alone, and one North Texas woman is making sure of that. Leslie Williams is the founder of Survivors on Purpose.
It’s long been known that faulty BRCA genes greatly raise the risk for breast cancer. Now scientists say a more recently identified, less common gene can do the same.
The Texas Department of State Health Services has released a new report which indicated most cancer rates in Flower Mound over a ten-year period were not higher than expected.
The new leader of the Susan G. Komen organization said that it has moved on from the controversy over its decision to stop giving grants to Planned Parenthood.
Police in Hurst are asking for help with finding the man who took advantage of a woman who was trying to raise money to pay for her breast cancer treatments.
3-D mammograms may be better at finding cancer than regular scans, a large study suggests. The study involved almost half a million breast scans, with more than one-third of them using relatively new 3-D imaging along with conventional scans.
Saturday is the annual Susan G. Komen Race for the Cure in Plano, and participant Paola Gerber talks about what it means to be a breast cancer ‘pre-vivor.’
Over the past decade, the phrases ‘BRCA 1’ and ‘BRCA 2’ went mainstream as genetic testing to assess breast cancer risk became common. But, now, doctors are telling patients whose tests were negative to get retested.
A Canadian study that many experts say has major flaws has revived debate about the value of mammograms.
Cleaning For A Reason is a nonprofit serving the entire U.S. and Canada, and has partnered with over 1,000 maid services to offer professional house cleanings to help women undergoing treatment for cancer. To date, Cleaning For A Reason has provided more than 17,000 cleanings for women, with a value of more than $4 million. Click here for more information.
A North Texas hospital is performing groundbreaking breast cancer research. Doctors are using cutting edge medical technology to customize treatment.
A novel way to speed the testing of cancer drugs and quickly separate winners from duds has yielded its first big result: an experimental medicine that shows promise against a hard-to-treat form of breast cancer.